Search

Author/Creator Ely, Scott

1. Carfilzomib and dexamethasone induction with lenalidomide, clarithromycin and dexamethasone consolidation and lenalidomide maintenance for newly diagnosed multiple myeloma. Issue 12 (4th September 2021)

Authors:
Forsberg, Peter A.; Rossi, Adriana C.; Boyer, Angelique; Pearse, Roger N.; Pekle, Karen A.; Jayabalan, David; Lakritz, Stephanie; Flicker, Kari; Ribadeneyra, Drew; Liotta, Brielle; Ely, Scott; Boussi, Leora; Allan, John N.; Coleman, Morton; Niesvizky, Ruben; Mark, Tomer M.
Journal:
American journal of hematology
Issue:
Volume 96:Issue 12(2021)
Page Start:
1554
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Cellular proliferation by multiplex immunohistochemistry identifies aggressive disease behavior in relapsed multiple myeloma. Issue 8 (3rd July 2019)

Authors:
Forsberg, Peter A.; Hammes, Andrew; Abbott, Diana; Sherbenou, Daniel W.; Rossi, Adriana; Jayabalan, David; Niesvizky, Ruben; Mark, Tomer M.; Ely, Scott
Journal:
Leukemia & lymphoma
Issue:
Volume 60:Issue 8(2019)
Page Start:
2085
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Phase I study of the anti-CD74 monoclonal antibody milatuzumab (hLL1) in patients with previously treated B-cell lymphomas. Issue 11 (2nd November 2015)

Authors:
Martin, Peter; Furman, Richard R.; Rutherford, Sarah; Ruan, Jia; Ely, Scott; Greenberg, June; Coleman, Morton; Goldsmith, Stanley J.; Leonard, John P.
Journal:
Leukemia & lymphoma
Issue:
Volume 56:Issue 11(2015:Nov.)
Page Start:
3065
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Phase II study of carfilzomib and dexamethasone therapy for newly diagnosed multiple myeloma. Issue 5 (25th February 2019)

Authors:
Forsberg, Peter A.; Rossi, Adriana C.; Boyer, Angelique; Tegnestam, Linda; Pearse, Roger N.; Perry, Arthur; Pekle, Karen A.; Jayabalan, David; Ely, Scott; Boussi, Leora; Sherbenou, Daniel W.; Williams, Colt; Allan, John N.; Coleman, Morton; Niesvizky, Ruben; Mark, Tomer M.
Journal:
American journal of hematology
Issue:
Volume 94:Issue 5(2019:May)
Page Start:
539
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Thalidomide, clarithromycin, lenalidomide and dexamethasone therapy in newly diagnosed, symptomatic multiple myeloma. Issue 12 (December 2014)

Authors:
Mark, Tomer M.; Bowman, Isaac A.; Rossi, Adriana C.; Shah, Manan; Rodriguez, Melissa; Quinn, Ryann; Pearse, Roger N.; Zafar, Faiza; Pekle, Karen; Jayabalan, David; Ely, Scott; Coleman, Morton; Chen-Kiang, Selina; Niesvizky, Ruben
Journal:
Leukemia & lymphoma
Issue:
Volume 55:Issue 12(2014:Dec.)
Page Start:
2842
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. The path to a better biomarker: application of a risk management framework for the implementation of PD‐L1 and TILs as immuno‐oncology biomarkers in breast cancer clinical trials and daily practice. Issue 5 (9th April 2020)

Authors:
Gonzalez‐Ericsson, Paula I; Stovgaard, Elisabeth S; Sua, Luz F; Reisenbichler, Emily; Kos, Zuzana; Carter, Jodi M; Michiels, Stefan; Le Quesne, John; Nielsen, Torsten O; Lænkholm, Anne‐Vibeke; Fox, Stephen B; Adam, Julien; Bartlett, John MS; Rimm, David L; Quinn, Cecily; Peeters, Dieter; Dieci, M...
Journal:
Journal of pathology
Issue:
Volume 250:Issue 5(2020)
Page Start:
667
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗